Does combined ASCA and pANCA testing yield higher diagnostic accuracy than either marker alone for distinguishing CD from UC

What is known

- For UC, the pANCA-positive/ASCA-negative combination gave sensitivity 50% and specificity 90%, described as more accurate than pANCA alone (sensitivity 50%, specificity 82%). ¹ - For CD, the ASCA-positive/pANCA-negative combination lowered sensitivity to 32% (from 40% for ASCA alone) with specificity unchanged at 100%. ¹ - A review reported combined markers yielded higher specificity than sensitivity, making them more useful for differentiating IBD subtypes than for population screening. ² - In a Greek cohort, adding negative ASCA to positive pANCA did not significantly change UC performance, but pANCA-negative/ASCA-positive raised PPV for CD to 77%. ³

What is unknown / caveats

- One cohort found the pANCA+/ASCA- combination more accurate than pANCA alone for UC ¹, while the combination did not improve CD diagnosis in the same study ¹ - A Greek study found combining markers did not significantly change UC test performance but raised PPV for CD ³ - Small samples (e.g., only 16 UC patients in the main cohort) and single-center/referral populations may inflate predictive values ¹ - Consistently low sensitivity means these markers cannot replace current diagnostic tools ¹ - Whether combined testing improves accuracy depends on which disease is being identified and the metric prioritized. Gains are in specificity, not sensitivity.

## References

1. Anand V, Russell AS, Tsuyuki R, Fedorak R. Perinuclear antineutrophil cytoplasmic autoantibodies and anti-Saccharomyces cerevisiae antibodies as serological markers are not specific in the identification of Crohn's disease and ulcerative colitis. Can J Gastroenterol. 2008;22(1):33-6. PMID: 18209778.

2. Turkay C, Kasapoglu B. Noninvasive methods in evaluation of inflammatory bowel disease: where do we stand now? An update. Clinics (Sao Paulo). 2010;65(2):221-31. PMID: 20186307.

3. Koutroubakis IE, Petinaki E, Mouzas IA, Vlachonikolis IG, Anagnostopoulou E, Castanas E, Maniatis AN, Kouroumalis EA. Anti-Saccharomyces cerevisiae mannan antibodies and antineutrophil cytoplasmic autoantibodies in Greek patients with inflammatory bowel disease. Am J Gastroenterol. 2001;96(2):449-54. PMID: 11232689.

For educational use only, not a substitute for clinical judgement or medical advice. Consult qualified clinicians for diagnosis and treatment decisions. This tool may contain errors; use the flag button below to report inaccurate or harmful content.

---

_Draft, generated by the IBDology RAG and not yet clinician-reviewed. Answers are grounded in the retrieved literature listed above; a high faithfulness score means the answer matches its sources, not that the sources are correct._